Equivalence of the assessment-only and intervention arms on sociodemographic, prognostic, and cancer treatments received variables (n = 62)
| Variables | Assessment only (n = 33) | Intervention (n = 29) |
|---|---|---|
| Mean (SD)/% | Mean (SD)/% | |
| Sociodemographic variables at recurrence | ||
| Age (y) | 52.2 (10.8) | 55.5 (11.9) |
| Race (% Caucasian) | 94 | 90 |
| Education (y) | 14.0 (2.3) | 14.9 (2.7) |
| Marital status (% married) | 67 | 66 |
| Family income (thousand $/year) | 51.6 (39.7) | 54.2 (40.6) |
| Initial diagnosis | ||
| Stage (II vs. III, % II) | 91 | 86 |
| Nodes (number positive) | 4.8 (7.3) | 4.9 (9.1) |
| ER/PR (% positive) | 55 | 55 |
| Treatments for initial diagnosis | ||
| Surgery (% modified radical mastectomy) | 61 | 62 |
| Chemotherapy (% yes) | 85 | 83 |
| Radiation therapy (% yes) | 49 | 45 |
| Hormonal therapy (% yes) | 73 | 62 |
| Recurrence diagnosis | ||
| Median disease-free interval (mo) | 26.0 | 33.0 |
| Site of recurrent disease (%) | ||
| Local | 29 | 18 |
| Regional | 0 | 7 |
| Distant | 71 | 75 |
| Bone only | 45 | 33 |
| Distant, other | 55 | 67 |
| Treatments for recurrence diagnosis | ||
| Surgery (% yes)* | 43 | 14 |
| Chemotherapy (% yes) | 47 | 57 |
| Radiation therapy (% yes) | 40 | 18 |
| Hormonal therapy (% yes) | 47 | 50 |
| Bone marrow transplantation (% yes) | 3 | 11 |